identifeye HEALTH

identifeye HEALTH

AI platform for retinal image analysis

About identifeye HEALTH

Simplify's Rating
Why identifeye HEALTH is rated
B
Rated B on Competitive Edge
Rated A on Growth Potential
Rated C on Rating Differentiation

Industries

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$80M

Headquarters

Guilford, Connecticut

Founded

2018

Overview

Identifeye Health focuses on improving medical diagnostics through the use of artificial intelligence, specifically in the area of retinal imaging. Their platform enables non-specialists, such as general practitioners, to capture and analyze retinal images in real-time, which helps in providing immediate health insights. This technology makes it easier for healthcare providers to diagnose and treat diseases earlier, as it broadens access to important health information. Unlike many competitors, Identifeye Health's system is designed for use by non-specialists, making it more accessible in various healthcare settings. The company's goal is to enhance early diagnosis and treatment of diseases by providing a user-friendly imaging platform that can be utilized in clinics and hospitals.

Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration in retinal imaging is gaining traction in healthcare.
  • The market for AI in medical imaging is projected to grow significantly by 2028.
  • AI in point-of-care diagnostics is increasingly adopted, aligning with Identifeye's approach.

What critics are saying

  • Tesseract Health's $80 million funding could overshadow Identifeye's offerings.
  • Michael McConnell's appointment at Tesseract may advance their competitive technology.
  • Tesseract Health's advancements could threaten Identifeye's market position.

What makes identifeye HEALTH unique

  • Identifeye Health uses AI to provide real-time retinal imaging analysis.
  • Their platform allows non-specialists to capture and analyze retinal images easily.
  • Identifeye Health democratizes access to health insights through non-invasive retinal imaging.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$80M

Above

Industry Average

Funded Over

1 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
Linktree
$65M
Substack
$80M
 identifeye HEALTH
$100M
ClickUp

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Hybrid Work Options

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-1%

2 year growth

0%
Cardiac Vascular News
Apr 29th, 2022
Tesseract Health hires Michael McConnell as Head of Cardiovascular and Digital Health

Tesseract Health, a health technology company developing a portable, non-invasive platform to detect health conditions through the eyes, proudly announces the appointment of Michael McConnell, MD, MSEE, as Tesseract’s Head of Cardiovascular and Digital Health.

Business Wire
Apr 20th, 2021
Tesseract Health Closes Oversubscribed $80 Million Series B Financing

GUILFORD, Conn.--(BUSINESS WIRE)--Tesseract Health Inc. has raised $80 million in an oversubscribed Series B financing round.

There are no jobs for identifeye HEALTH right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →